GlassScriptPhysician profile
Eric Schnakenberg
NPI 1831128206
$189,902.93
in general payments reported to CMS, 2019-2025
56 companies · $56K in 2025
The $56K reported for 2025 was more than what 99% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,436 · 2020: $539 · 2021: $15K · 2022: $32K · 2023: $52K · 2024: $32K · 2025: $56K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $117K · Travel and Lodging: $13K · Food and Beverage: $9,528.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $116,750.00 |
| Travel and Lodging | $13,424.56 |
| Food and Beverage | $9,527.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $180,687.84 | 2019-2025 | Bexsero, Shingrix, Arexvy |
| Abbvie INC. | $1,512.22 | 2019-2025 | Vraylar, Qulipta, Ubrelvy |
| Novo Nordisk INC | $1,244.67 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,103.39 | 2019-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $761.86 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Pfizer INC. | $507.53 | 2019-2025 | |
| Abbott Laboratories | $389.54 | 2019-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Amgen INC. | $375.00 | 2019-2025 | Repatha, Otezla, Repatha |
| Astellas Pharma US INC | $332.73 | 2019-2025 | Veozah, Myrbetriq |
| Sanofi-Aventis U.S. LLC | $306.13 | 2019-2025 | |
| Lilly USA, LLC | $287.70 | 2019-2025 | Zepbound, Mounjaro, Jardiance |
| Merck Sharp & Dohme LLC | $233.12 | 2019-2025 | Capvaxive, Gardasil 9 |
| Bayer Healthcare Pharmaceuticals INC. | $182.75 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $180.99 | 2019-2021 | |
| Amarin Pharma, INC. | $159.48 | 2019-2021 |
Show all 56 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $145.60 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $130.11 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $128.78 | 2019-2024 | Trintellix |
| Dexcom, INC. | $91.05 | 2021-2024 | Dexcom G6 Transmitter |
| Seqirus USA INC | $73.48 | 2020-2023 | Flucelvax Quadrivalent, Fluad Quadrivalent |
| Allergan, INC. | $69.91 | 2019 | |
| Silk Road Medical, INC. | $69.44 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Sumitomo Pharma America, INC. | $63.67 | 2023-2024 | Gemtesa |
| Renalytix Ai, INC. | $57.88 | 2022-2024 | Kidneyintelx Blood Collection Convenience Kit |
| Exact Sciences Corporation | $53.82 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Avanir Pharmaceuticals, INC. | $47.82 | 2019-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $45.36 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $45.28 | 2019-2025 | Camzyos |
| Lundbeck LLC | $39.88 | 2024-2025 | Rexulti |
| Ucb, INC. | $35.35 | 2023 | Nayzilam |
| Phathom Pharmaceuticals, INC. | $32.99 | 2025 | Voquezna |
| Teva Pharmaceuticals USA, INC. | $31.08 | 2019 | |
| Sk Life Science, INC. | $30.83 | 2023 | |
| Esperion Therapeutics, INC. | $30.50 | 2025 | Nexletol |
| Boston Scientific Corporation | $28.03 | 2025 | Watchman Flx |
| Edwards Lifesciences Corporation | $25.48 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $22.92 | 2024 | Rexulti |
| Viatris Specialty LLC | $22.31 | 2025 | Yupelri |
| Shire North American Group INC | $21.28 | 2019 | |
| Jazz Pharmaceuticals INC. | $21.14 | 2021 | |
| Verona Pharma, INC. | $20.81 | 2025 | Ohtuvayre |
| Axsome Therapeutics, INC. | $20.02 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.00 | 2025 | Xifaxan |
| Medtronic, INC. | $19.60 | 2023 | Inpen Smart Insulin Delivery System |
| Agile Therapeutics, INC. | $19.26 | 2022 | |
| Horizon Therapeutics Plc | $18.52 | 2023 | Krystexxa |
| Kowa Pharmaceuticals America, INC. | $18.37 | 2024 | Zoryve |
| Corium, LLC | $18.29 | 2023 | Azstarys |
| Alnylam Pharmaceuticals INC. | $18.15 | 2024 | Givlaari |
| Genentech USA, INC. | $17.01 | 2019 | |
| Daiichi Sankyo INC. | $16.71 | 2024 | Injectafer |
| Indivior INC. | $14.96 | 2019 | |
| Ibsa Pharma INC. | $13.71 | 2025 | Tirosint, Licart, Flector |
| Mylan Specialty L.P. | $13.21 | 2024 | Yupelri |
| Biohaven Pharmaceuticals, INC. | $12.96 | 2021 | |
| Vertical Pharmaceuticals, LLC | $12.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Schnakenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.